Preserved Cardiac Function Despite Marked Impairment of CAMP Generation

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Oct 23

PMID 24147149

Citations 7

Authors

Mei Hua Gao

Ngai Chin Lai

Tong Tang

Tracy Guo

Ruoying Tang

Byeong Jo Chun

Hong Wang

Nancy N Dalton

Jorge Suarez

Wolfgang H Dillmann

H Kirk Hammond

Affiliations

Soon will be listed here.

Abstract

Objectives: So many clinical trials of positive inotropes have failed, that it is now axiomatic that agents that increase cAMP are deleterious to the failing heart. An alternative strategy is to alter myocardial Ca(2+) handling or myofilament response to Ca(2+) using agents that do not affect cAMP. Although left ventricular (LV) function is tightly linked to adenylyl cyclase (AC) activity, the beneficial effects of AC may be independent of cAMP and instead stem from effects on Ca(2+) handling. Here we ask whether an AC mutant molecule that reduces LV cAMP production would have favorable effects on LV function through its effects on Ca(2+) handling alone.

Methods And Results: We generated transgenic mice with cardiac-directed expression of an AC6 mutant (AC6mut). Cardiac myocytes showed impaired cAMP production in response to isoproterenol (74% reduction; p<0.001), but LV size and function were normal. Isolated hearts showed preserved LV function in response to isoproterenol stimulation. AC6mut expression was associated with increased sarcoplasmic reticulum Ca(2+) uptake and the EC50 for SERCA2a activation was reduced. Cardiac myocytes isolated from AC6mut mice showed increased amplitude of Ca(2+) transients in response to isoproterenol (p = 0.0001). AC6mut expression also was associated with increased expression of LV S100A1 (p = 0.03) and reduced expression of phospholamban protein (p = 0.01).

Conclusion: LV AC mutant expression is associated with normal cardiac function despite impaired cAMP generation. The mechanism appears to be through effects on Ca(2+) handling - effects that occur despite diminished cAMP.

Citing Articles

Physiological roles of mammalian transmembrane adenylyl cyclase isoforms.

Ostrom K, LaVigne J, Brust T, Seifert R, Dessauer C, Watts V Physiol Rev. 2021; 102(2):815-857.

PMID: 34698552 PMC: 8759965. DOI: 10.1152/physrev.00013.2021.

Cardiac-Directed Expression of Adenylyl Cyclase Catalytic Domain () Attenuates Deleterious Effects of Pressure Overload.

Tan Z, Giamouridis D, Lai N, Kim Y, Guo T, Xia B Hum Gene Ther. 2019; 30(6):682-692.

PMID: 30638074 PMC: 6589496. DOI: 10.1089/hum.2018.176.

Fine Tuning Adenylyl Cyclase as a (Gene) Therapy for Heart Failure.

Port J, Bristow M JACC Basic Transl Sci. 2018; 1(7):630-632.

PMID: 30167546 PMC: 6113554. DOI: 10.1016/j.jacbts.2016.10.005.

Effects of Urocortin 2 Versus Urocortin 3 Gene Transfer on Left Ventricular Function and Glucose Disposal.

Giamouridis D, Gao M, Lai N, Tan Z, Kim Y, Guo T JACC Basic Transl Sci. 2018; 3(2):249-264.

PMID: 30062211 PMC: 6059348. DOI: 10.1016/j.jacbts.2017.12.004.

Cardiac-directed expression of a catalytically inactive adenylyl cyclase 6 protects the heart from sustained β-adrenergic stimulation.

Gao M, Lai N, Giamouridis D, Kim Y, Guo T, Hammond H PLoS One. 2017; 12(8):e0181282.

PMID: 28767701 PMC: 5540275. DOI: 10.1371/journal.pone.0181282.

References

Luo W, Chu G, Sato Y, Zhou Z, Kadambi V, Kranias E . Transgenic approaches to define the functional role of dual site phospholamban phosphorylation. J Biol Chem. 1998; 273(8):4734-9. DOI: 10.1074/jbc.273.8.4734. View

Chu G, Lester J, Young K, Luo W, Zhai J, Kranias E . A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta -agonists. J Biol Chem. 2000; 275(49):38938-43. DOI: 10.1074/jbc.M004079200. View

Roth D, Bayat H, Drumm J, Gao M, Swaney J, Ander A . Adenylyl cyclase increases survival in cardiomyopathy. Circulation. 2002; 105(16):1989-94. DOI: 10.1161/01.cir.0000014968.54967.d3. View

Iancu R, Ramamurthy G, Harvey R . Spatial and temporal aspects of cAMP signalling in cardiac myocytes. Clin Exp Pharmacol Physiol. 2008; 35(11):1343-8. DOI: 10.1111/j.1440-1681.2008.05020.x. View

Most P, Remppis A, Pleger S, Loffler E, Ehlermann P, Bernotat J . Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. J Biol Chem. 2003; 278(36):33809-17. DOI: 10.1074/jbc.M301788200. View

Takahashi T, Tang T, Lai N, Roth D, Rebolledo B, Saito M . Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction. Circulation. 2006; 114(5):388-96. DOI: 10.1161/CIRCULATIONAHA.106.632513. View

Tang T, Gao M, Lai N, Firth A, Takahashi T, Guo T . Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling. Circulation. 2007; 117(1):61-9. DOI: 10.1161/CIRCULATIONAHA.107.730069. View

Engelhardt S, Hein L, Wiesmann F, Lohse M . Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A. 1999; 96(12):7059-64. PMC: 22055. DOI: 10.1073/pnas.96.12.7059. View

Antos C, Frey N, Marx S, Reiken S, Gaburjakova M, Richardson J . Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a. Circ Res. 2001; 89(11):997-1004. DOI: 10.1161/hh2301.100003. View

10.

Tang T, Gao M, Roth D, Guo T, Hammond H . Adenylyl cyclase type VI corrects cardiac sarcoplasmic reticulum calcium uptake defects in cardiomyopathy. Am J Physiol Heart Circ Physiol. 2004; 287(5):H1906-12. DOI: 10.1152/ajpheart.00356.2004. View

11.

Song W, Zimmer D . Expression of the rat S100A1 gene in neurons, glia, and skeletal muscle. Brain Res. 1996; 721(1-2):204-16. DOI: 10.1016/0006-8993(96)00172-2. View

12.

Roth D, Gao M, Lai N, Drumm J, Dalton N, Zhou J . Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy. Circulation. 1999; 99(24):3099-102. DOI: 10.1161/01.cir.99.24.3099. View

13.

Liggett S, Tepe N, Lorenz J, Canning A, Jantz T, Mitarai S . Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation. 2000; 101(14):1707-14. DOI: 10.1161/01.cir.101.14.1707. View

14.

Ostrom R, Post S, Insel P . Stoichiometry and compartmentation in G protein-coupled receptor signaling: implications for therapeutic interventions involving G(s). J Pharmacol Exp Ther. 2000; 294(2):407-12. View

15.

Lai N, Roth D, Gao M, Tang T, Dalton N, Lai Y . Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure. Circulation. 2004; 110(3):330-6. DOI: 10.1161/01.CIR.0000136033.21777.4D. View

16.

Efendiev R, Samelson B, Nguyen B, Phatarpekar P, Baameur F, Scott J . AKAP79 interacts with multiple adenylyl cyclase (AC) isoforms and scaffolds AC5 and -6 to alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptors. J Biol Chem. 2010; 285(19):14450-8. PMC: 2863235. DOI: 10.1074/jbc.M110.109769. View

17.

Mayr B, Montminy M . Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001; 2(8):599-609. DOI: 10.1038/35085068. View

18.

Bristow M, Ginsburg R, Minobe W, Cubicciotti R, Sageman W, Lurie K . Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982; 307(4):205-11. DOI: 10.1056/NEJM198207223070401. View

19.

Packer M, Carver J, Rodeheffer R, Ivanhoe R, DiBianco R, Zeldis S . Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991; 325(21):1468-75. DOI: 10.1056/NEJM199111213252103. View

20.

Brittsan A, Kranias E . Phospholamban and cardiac contractile function. J Mol Cell Cardiol. 2000; 32(12):2131-9. DOI: 10.1006/jmcc.2000.1270. View